Ashley Chan

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma.

During summer 2024, there have been many changes made in the non-small cell lung cancer and small cell lung cancer spaces. Here are four top news stories.

From the lead singer of Heart’s cancer diagnosis and postponing their tour to Dick Vitale’s upcoming cancer surgery, here’s what’s going on in the cancer space this week.

For survivors who had received cisplatin chemotherapy, an expert advised routine hearing checks and wearing earplugs in loud places to maintain hearing.

For patients with endometrial cancer that is dMMR, the two new drug approvals lead to more options, with a new option for patients with pMMR disease, too.

Before enrolling in a clinical trial for metastatic breast cancer, it’s important to know which are best suited for each individual, an expert said.

For patients with MDS who benefit from delaying transplants, it’s important to take care of their health while savoring their time before transplant.

From Judge Frank Caprio opening up about his diagnosis of pancreatic cancer and treatment to an “Ink Master” star dying from testicular cancer, here’s what’s going on in the oncology space this week.

The Food and Drug Administration approved Epkinly, a bispecific T-cell engager, for certain patients with follicular lymphoma.

Talking about the good, bad and ugly aspects of cancer on social media is “the most healing part of this community,” a survivor said.

In children with T-lymphoblastic lymphoma, having an MRD status of less than 0.1% may lead to more time without their cancer worsening or coming back.

Imdelltra has offered a new treatment option for patients with small cell lung cancer that “is not like anything we’ve ever seen before,” an expert said.

For patients with kidney cancer undergoing postsurgical treatments, it’s key to understand how immunotherapy works and what side effects to look for.

From Don Omar announcing being cancer free to “General Hospital” star John York talking about treatment for his two cancers, here’s what’s going on in the oncology space this week.

Patients with lung cancer may have personalized treatment options after biomarker testing, an expert said at the CURE® Educated Patient® Lung Cancer Summit.

Treatment for lung cancer has changed significantly with immunotherapy, an expert said during the CURE® Educated Patient® Lung Cancer Summit.

Leaning on spiritual belief may strengthen patients' life purposes, but for many, it's common to temporarily loosen their grip on faith after a cancer diagnosis.

The FDA approved Blincyto for patients aged one month and older with CD19-positive, Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

From Kate Middleton giving an update on her cancer treatment to Kevin Jonas’ skin cancer surgery, here’s what’s happening in the oncology space this week.

Quality of life may temporarily worsen after patients with myeloma receive stem cell transplants, said an expert at the Educated Patient® Multiple Myeloma Summit.

Having social media platforms to share breast cancer experiences changes the narrative for others who may empathize, a survivor and advocate said.

For patients with non-small lung cancer and brain metastases, it’s important to consent to shaving the scalp before tumor-treating fields therapy.

The safety profile of 200 milligrams and 300 milligrams of oral Ongureg were similar in patients with lower- to intermediate-risk MDS.

From NBA Hall of Famer Bill Walton dying from cancer to an ancient skull showing evidence of early cancer treatments, here’s what’s happening in the oncology space this week.

Sarclisa was granted a priority review by the Food and Drug Administration for patients newly diagnosed with multiple myeloma who are ineligible for blood transplants.

The FDA has approved several treatments for patients with solid tumors. Here are five recently approved treatments.

Bladder-conserving treatment may be beneficial for certain patients with non-muscle-invasive bladder cancer, and may not be for those with high-risk disease.

Using tests to identify minimal residual disease may help determine how much treatment patients with multiple myeloma require.

Aerobic and strength training exercises may help preserve physical functioning in older adults with early-stage breast cancer who received chemotherapy.

Onivyde did not outperform chemotherapy in improving outcomes for patients with relapsed small cell lung cancer, despite having better response rates.